InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: NASDAQ2020 post# 292763

Saturday, 06/30/2018 9:45:42 PM

Saturday, June 30, 2018 9:45:42 PM

Post# of 402218

Let’s do 1/4 the market to keep it conservative.
Each patient pays $1200/ year.







Hello Dianne,

We're all looking forward to the STEADY-PD Phase 3 results to be published in early 2019. As far as I can tell, isradipine is not currently available in Canada. Would the company consider applying with HealthCanada to market isradipine? I read there are an estimated 100,000 patients with Parkinson's Disease in Canada. If the study results are good, those patients are going to need a reliable supplier of the drug. Maybe that could be Elite!



Thanks,










Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News